1. Home
  2. ALRS vs ODTX Comparison

ALRS vs ODTX Comparison

Compare ALRS & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

HOLD

Current Price

$32.98

Market Cap

821.7M

Sector

Finance

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$17.94

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALRS
ODTX
Founded
1879
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.7M
875.1M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
ALRS
ODTX
Price
$32.98
$17.94
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$25.40
N/A
AVG Volume (30 Days)
203.9K
269.4K
Earning Date
04-29-2026
N/A
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
N/A
N/A
Revenue This Year
$38.42
N/A
Revenue Next Year
$4.68
N/A
P/E Ratio
$37.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.26
$15.10
52 Week High
$33.44
$20.00

Technical Indicators

Market Signals
Indicator
ALRS
ODTX
Relative Strength Index (RSI) 73.04 50.19
Support Level $30.13 $17.38
Resistance Level N/A $19.60
Average True Range (ATR) 0.68 1.41
MACD 0.05 0.19
Stochastic Oscillator 91.17 67.93

Price Performance

Historical Comparison
ALRS
ODTX

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: